about
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) huma...
Read More
3.81
0.09
(2.42%)
78,145
XNAS Volume
XNAS 23 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
VivoSim Labs Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..